4-Hydroxy-5-hydroxymethyl-2-oxo-2,5-dihydro-furan-3-carboxylic acid octadeca-9,12,15-trienyl ester

ID: ALA111387

Chembl Id: CHEMBL111387

Max Phase: Preclinical

Molecular Formula: C24H36O6

Molecular Weight: 420.55

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC/C=C/C/C=C/C/C=C/CCCCCCCCOC(=O)C1=C(O)O[C@H](CO)C1=O

Standard InChI:  InChI=1S/C24H36O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-29-23(27)21-22(26)20(19-25)30-24(21)28/h3-4,6-7,9-10,20,25,28H,2,5,8,11-19H2,1H3/b4-3+,7-6+,10-9+/t20-/m1/s1

Standard InChI Key:  NGUNKFRQCRSBAO-HGLTYHETSA-N

Alternative Forms

  1. Parent:

    ALA111387

    ---

Associated Targets(Human)

DUSP3 Tchem Dual specificity protein phosphatase 3 (1161 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cdc25b Dual specificity phosphatase Cdc25B (32 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 420.55Molecular Weight (Monoisotopic): 420.2512AlogP: 4.85#Rotatable Bonds: 16
Polar Surface Area: 93.06Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 0.36CX Basic pKa: CX LogP: 6.31CX LogD: 2.75
Aromatic Rings: 0Heavy Atoms: 30QED Weighted: 0.16Np Likeness Score: 1.33

References

1. Sodeoka M, Sampe R, Kojima S, Baba Y, Usui T, Ueda K, Osada H..  (2001)  Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dual-specificity protein phosphatases and its evaluation regarding VHR and cdc25B inhibition.,  44  (20): [PMID:11563920] [10.1021/jm0100741]

Source